Using anti-cancer immunotherapy to fight HIV

Researchers at the University of Montreal Hospital Research Centre (CRCHUM) have shown that immunotherapy treatments against cancer could reduce the amount of virus that persists in people on triple therapy. In a study published ...

Medical research

A ratiometric fluorescence probe for cisplatin

NUS chemists have developed a novel ratiometric fluorescence probe for studying cellular activity of the clinically important anticancer drug cisplatin for next generation drug development.


Advancing therapy by measuring the 'games' cancer cells play

Despite rapid advances in targeted therapies for cancer, tumors commonly develop resistance to treatment. When resistance emerges, tumor cells continue to grow unchecked, despite all attempts to slow cancer progression. While ...

page 1 from 2